comparemela.com

Latest Breaking News On - Freya pharma solutions - Page 1 : comparemela.com

Female Sexual Dysfunction Treatment Market to grow by USD 7.76 billion from 2022-2027; North America to account for 61% of market growth

/PRNewswire/ The female sexual dysfunction treatment market size is expected to grow by USD 7.76 billion from 2022 to 2027. In addition, the momentum of the.

United-kingdom
United-states
America
American
Jesse-maida
Assos-ilac
Cipla-ltd
Company-landscape
Pfizer-inc
Endo-international-plc
Viatris-inc
Novo-nordisk

Freya Pharma Solutions Announces Response from the FDA on its US Clinical Development Program of LybridoTM for the treatment of Female Sexual Interest/Arousal Disorder

Freya Pharma Solutions Announces Advice from the FDA on its US Clinical Development Program of Lybrido for the treatment of Female Sexual Interest/Arousal Disorder

AMSTERDAM, May 9, 2023 /PRNewswire/ Freya Pharma Solutions, a pharmaceutical company focusing on the development of effective pharmaceutical therapies for women diagnosed with Female Sexual

Amsterdam
Noord-holland
Netherlands
United-states
American
Marcel-wijma
Us-clinical-development-program-of-lybrido
European-medicines-agency
Drug-administration
American-psychiatric-association
Freya-pharma-solutions
Prnewswire-freya-pharma-solutions

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.